Cargando…
IL-10–producing Th1 cells possess a distinct molecular signature in malaria
Autores principales: | Edwards, Chelsea L., Ng, Susanna S., de Labastida Rivera, Fabian, Corvino, Dillon, Engel, Jessica A., Montes de Oca, Marcela, Bukali, Luzia, Frame, Teija C.M., Bunn, Patrick T., Chauhan, Shashi Bhushan, Singh, Siddharth Sankar, Wang, Yulin, Na, Jinrui, Amante, Fiona H., Loughland, Jessica R., Soon, Megan S.F., Waddell, Nicola, Mukhopadhay, Pamela, Koufariotis, Lambros T., Johnston, Rebecca L., Lee, Jason S., Kuns, Rachel, Zhang, Ping, Boyle, Michelle J., Hill, Geoffrey R., McCarthy, James S., Kumar, Rajiv, Engwerda, Christian R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society for Clinical Investigation
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9927919/ https://www.ncbi.nlm.nih.gov/pubmed/36787259 http://dx.doi.org/10.1172/JCI169299 |
Ejemplares similares
-
IL-10-producing Th1 cells possess a distinct molecular signature in malaria
por: Edwards, Chelsea L., et al.
Publicado: (2023) -
STING activation promotes autologous type I interferon–dependent development of type 1 regulatory T cells during malaria
por: Wang, Yulin, et al.
Publicado: (2023) -
Increased amphiregulin expression by CD4(+) T cells from individuals with asymptomatic Leishmania donovani infection
por: Singh, Siddharth Sankar, et al.
Publicado: (2022) -
IL-27 signalling regulates glycolysis in Th1 cells to limit immunopathology during infection
por: Montes de Oca, Marcela, et al.
Publicado: (2020) -
Type I Interferons Suppress Anti-parasitic Immunity and Can Be Targeted to Improve Treatment of Visceral Leishmaniasis
por: Kumar, Rajiv, et al.
Publicado: (2020)